Índice Bovespa

US Dollar vs BRL

Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.

Cadastre-se

Início
Investir
Ações
Reino Unido
LSE
Crism Therapeutics Corporation (CRTX)
Crism Therapeutics Corporation (CRTX) Notícias

CRTX

Crism Therapeutics (CRTX)

Crism Therapeutics Corporation

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:LSE:CRTX

1

Data	Hora	Fonte	Título	Código	Companhia
03/06/2024	11:25	RNS Regulatory News	Crism Therapeutics Corporation Director Dealing	LSE:CRTX	Crism Therapeutics Corporation
31/05/2024	17:58	Alliance News	IN BRIEF: Crism has first day of trade on AIM after name change, buy	LSE:CRTX	Crism Therapeutics Corporation
31/05/2024	03:00	RNS Regulatory News	Crism Therapeutics Corporation Admission to Trading and First Day of Dealings	LSE:CRTX	Crism Therapeutics Corporation
18/12/2009	16:45	PR Newswire (US)	Cornerstone Therapeutics to Host Conference Call to Discuss Financial Guidance for 2010	NASDAQ:CRTX
20/11/2009	18:40	PR Newswire (US)	Cornerstone Therapeutics Provides a Response to FDA Warning Letter on Deconsal	NASDAQ:CRTX
16/11/2009	11:00	PR Newswire (US)	Cornerstone Therapeutics to Present at the 6th Annual Lazard Capital Markets Healthcare Conference	NASDAQ:CRTX
13/11/2009	11:00	PR Newswire (US)	Cornerstone Therapeutics Appoints General Counsel	NASDAQ:CRTX
04/11/2009	10:00	PR Newswire (US)	Cornerstone Therapeutics Reports Third Quarter 2009 Financial Results	NASDAQ:CRTX
21/10/2009	10:00	PR Newswire (US)	Cornerstone Therapeutics to Host Third Quarter 2009 Conference Call	NASDAQ:CRTX
03/09/2009	09:01	PR Newswire (US)	Cornerstone Therapeutics Receives Approval to Acquire Commercial Rights to the Antibiotic Factive(R)	NASDAQ:CRTX
03/09/2009	09:00	PR Newswire (US)	Cornerstone Therapeutics to Present at Two Upcoming Investor Conferences	NASDAQ:CRTX
20/07/2009	09:00	PR Newswire (US)	Cornerstone Therapeutics' David Price Named 2009 Chief Financial Officer of the Year by the Triangle Business Journal	NASDAQ:CRTX
15/07/2009	20:04	PR Newswire (US)	Cornerstone Therapeutics Submits Regulatory Filing for Extended-Release Antitussive Product	NASDAQ:CRTX
08/07/2009	17:15	PR Newswire (US)	Cornerstone Therapeutics Inc. Announces Record Date and Meeting Date for Special Meeting of Stockholders for Vote with Respect t	NASDAQ:CRTX
12/06/2009	17:35	Dow Jones News	UPDATE:FDA Updates Singulair Label For Neuropsychiatric Events	NASDAQ:CRTX	Cornerstone Therapeutics Inc.
12/06/2009	16:28	Dow Jones News	FDA: Updates Singulair Label For Neuropsychiatric Events	NASDAQ:CRTX	Cornerstone Therapeutics Inc.
19/05/2009	17:01	PR Newswire (US)	Cornerstone Therapeutics Announces Management Change	NASDAQ:CRTX
07/05/2009	08:01	PR Newswire (US)	Cornerstone Therapeutics Announces $70 Million Strategic Transaction With Chiesi Farmaceutici SpA	NASDAQ:CRTX
07/05/2009	08:00	PR Newswire (US)	Cornerstone Therapeutics Reports First Quarter 2009 Financial Results	NASDAQ:CRTX
27/04/2009	09:00	PR Newswire (US)	Cornerstone Therapeutics to Host First Quarter 2009 Conference Call	NASDAQ:CRTX
13/01/2009	20:33	Dow Jones News	UPDATE: Singular, Zyflo Asthma Drug Safety Review Continues	NASDAQ:CRTX	Cornerstone Therapeutics Inc.
13/01/2009	18:34	Dow Jones News	FDA: Singular, Zyflo Asthma Drug Safety Review Continues	NASDAQ:CRTX	Cornerstone Therapeutics Inc.
05/11/2008	11:00	PR Newswire (US)	Cornerstone Therapeutics Announces New Board of Directors	NASDAQ:CRTX
01/08/2006	11:00	PR Newswire (US)	Critical Therapeutics Files Controlled Release Formulation of Zileuton	NASDAQ:CRTX

Apresentando as notícias mais relevantes sobre:LSE:CRTX

1

Índice Bovespa

Delayed Upgrade Clock

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições